Modulation of radiosensitivity in Chinese hamster lung fibroblasts by cisplatin

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 5, 2008, Pages 257-263

  Akudugu, J M ^a   Slabbert, J P ^a  

^a ITHEMBA LABS   (South Africa)

Author keywords

Chinese hamster lung fibroblasts; Cisplatin; Radiosensitivity modification

Indexed keywords

CISPLATIN;

ARTICLE; CELL SURVIVAL; CHO CELL; CLONOGENESIS; CONCENTRATION RESPONSE; GAMMA IRRADIATION; LUNG FIBROBLAST; PRIORITY JOURNAL; RADIOBIOLOGY; RADIOSENSITIVITY; TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CELL SURVIVAL; CISPLATIN; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; INHIBITORY CONCENTRATION 50; LUNG; RADIATION-SENSITIZING AGENTS; TIME FACTORS;

EID: 43949125479     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-035     Document Type: Article

References (53)

1. Akudugu, J.M., and Böhm, L. 2001. Micronuclei and apoptosis in glioma and neuroblastoma cell lines and the role of other lesions in the reconstruction of cellular radiosensitivity. Radiat. Environ. Biophys. 40: 295-300. doi:10.1007/s00411-001-0121-8. PMID: 11820738.
2. Akudugu, J.M., Slabbert, J.P., Serafin, A., and Böhm, L. 2000. Frequency of radiation-induced micronuclei in neuronal cells does not correlate with clonogenic survival. Radiat. Res. 153: 62-67. PMID:10630978.
3. Akudugu, J.M., Abend, M., and Böhm, L. 2002. A unifying model for reconstructing radiosensitivity from micronucleus formation, apoptosis and abnormal morphology. Radiat. Environ. Biophys. 41: 267-274. PMID:12541072.
4. Allen, A.M., Zalupski, M.M., Robertson, J.M., Eckhauser, F.E., Simone, D., Brown, D., et al. 2004. Adjuvant therapy in pancreatic cancer: phase I trial of radiation dose escalation with concurrent full-dose gemcitabine. Int. J. Radiat. Oncol. Biol. Phys. 59: 1461-1467. PMID:15275733.
5. Bartelink, H., Kallman, R.F., Rappacchietta, D., and Hart, A.A.M. 1986. Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum(II) and irradiation. Radiother. Oncol. 6: 61-74. doi:10.1016/S0167-8140(86)80110-4. PMID:3715061.
6. Basham, C., Mills, J., Douple, E.B., and Roberts, J.J. 1989. The independent action of radiation and cisplatin on the survival or recovery of human normal or tumour cells in vitro. Int. J. Radiat. Biol. 55: 807-820. doi:10.1080/09553008914550851. PMID:2565941.
7. Begg, A.C., and Terry, N.H.A. 1984. The sensitivity of normal stroma to fractionated radiotherapy measured by a tumour growth rate assay. Radiother. Oncol. 2: 333-341. doi:10.1016/S0167-8140(84)80076-6. PMID:6084258.
8. Begg, A.C., Bohlken, S., and Bartelink, H. 1989. The effect of cisplatin on the repair of radiation damage in RIF 1 mouse tumours in vivo. Radiother. Oncol. 15: 79-91. doi:10.1016/0167-8140(89)90121-7. PMID:2748945.
9. Benzina, S., Fischer, B., Miternique-Grosse, A., Dufour, P., Denis, J.-M., Bergerat, J.-P., et al. 2006. Cell death induced in a human glioblastoma cell line by p(65)+Be neutrons combined with cisplatin. Life Sci. 79: 513-518. doi:10.1016/j.lfs.2006.01.037. PMID:16516239.
10. +) neutrons and 4 MeV photons by exposure to cisplatinum. Int. J. Radiat. Oncol. Biol. Phys. 26: 837-843. PMID:8344853.
11. Chen, S.-W., Liang, J.-A., Hung, Y.-C., Yeh, L.-S., Chang, W.-C., Lin, W.-C., et al. 2006. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications. Int. J. Radiat. Oncol. Biol. Phys. 66: 1370-1377. PMID:16979836.
12. Chua, D.T.T., Ma, J., Sham, J.S.T., Mai, H.-Q., Choy, D.T.K., Hong, M.-H., et al. 2006. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two phase III trials. Int. J. Radiat. Oncol. Biol. Phys. 65: 1300-1306. PMID:16750333.
13. Córdoba, S., Romero, J., De la Torre, A., Valcárcel, F., Magallón, R., Requeiro, C.A., and García-Berrocal, M.I. 2003. Early stage infradiaphragmatic Hodgkin's disease: results of radiotherapy and review of the literature. Radiother. Oncol. 67: 259-263. doi:10.1016/S0167-8140(03)00054-9. PMID:12865173.
14. Couderc, B., Dujols, J.-P., Mokhtari, F., Norkowski, J.-L., Slawinski, J.-C., and Schleifer, D. 2000. The management of adult aggressive Hodgkin's lymphomas. Crit. Rev. Oncol. Hematol. 35: 33-48. doi:10.1016/S1040- 8428(99)00037-2. PMID:10863150.
15. Crane, C.H., Abbruzzese, J.L., Evans, D.B., Wolff, R.A., Ballo, M.T., Delclos, M., et al. 2002. Is therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int. J. Radiat. Oncol. Biol. Phys. 52: 1293-1302. doi:10.1016/S0360-3016(01)02740-7. PMID:11955742.
16. Dewit, L., Oussoren, Y., and Bartelink, H. 1987. Early and late damage in the mouse rectum after irradiation and cis-diamminedichloroplatinum(II). Radiother. Oncol. 8: 57-69. doi:10.1016/S0167-8140(87)80023-3. PMID:3809602.
17. Dietrich III, C.S., Modesitt, S.C., DePriest, P.D., Ueland, F.R., Wilder, J., Reedy, M.B., et al. 2005. The efficacy of adjuvant platinum-based chemotherapy in stage I uterine papillary serous carcinoma. Gynecol. Oncol. 99: 557-563. doi:10.1016/j.ygyno.2005.07.104. PMID:16154185.
18. Douillard, J.-Y., Rosell, R., De Lena, M., Carpagnano, F., Ramlau, R., Gonzáles-Larriba, J.L., et al. 2006. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomized controlled trial. Lancet Oncol. 7: 719-727. doi:10.1016/S1470-2045(06)70804-X. PMID:16945766.
19. Ensley, J.F., Jacobs, J.R., Weaver, A., Kinzie, J., Crissman, J., Kish, J.A., et al. 1984. Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer, 54: 811-814. doi:10.1002/1097-0142(19840901)54:5〈811::AIDCNCR2820540508〉3.0.CO;2- E. PMID:6204738.
20. Fischer, B., Benzina, S., Ganansia-Leymarie, V., Denis, J.M., Bergerat, J.P., Dufour, P., et al. 2004. Cisplatin enhances the cytotoxicity of fast neutrons in a murine lymphoma cell line. Can. J. Physiol. Pharmacol. 82: 140-145. doi:10.1139/y04-007. PMID:15052295.
21. Fu, K.K., Rayner, P.A., and Lam, K.N. 1984. Modification of the effects of continuous low dose rate irradiation by concurrent chemotherapy infusion. Int. J. Radiat. Oncol. Biol. Phys. 10: 1473-1478. PMID:6206039.
22. Fu, K.K., Lam, K.N., and Rayner, P.A. 1985. The influence of time sequence of cisplatin administration and continuous low dose rate irradiation (CLDRI) on the combined effects on murine squamous cell carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 11: 2119-2124. PMID:4066444.
23. Gorodetsky, R., Levy-Agababa, F., Mou, X., and Vexler, A.M. 1998. Combination of cisplatin and radiation in cell culture: Effect of duration of exposure to drug and timing of irradiation. Int. J. Cancer, 75: 635-642. doi:10.1002/(SICI)1097-0215(19980209)75:4〈635::AID-IJC23〉3.0.CO;2-6. PMID:9466668.
24. Greven, K., Winter, K., Underhill, K., Fontenesci, J., Cooper, J., and Burke, T. 2006. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol. Oncol. 103: 155-159. doi:10.1016/j.ygyno.2006.02.007. PMID:16545437.
25. Jeong, H.C., Lee, S.Y., Lee, S.Y., Kim, J.H., Shin, C., Shim, J.J., et al. 2006. Phase II study of irinotecan plus cisplatin with concurrent radiotherapy for the patients with limited-disease small-cell lung cancer. Lung Cancer, 53: 361-366. doi:10.1016/j.lungcan.2006.06.002. PMID:16846662.
26. Jirsova, K., Mandys, V., Gispen, W.H., and Bär, P.R. 2006. Cisplatin-induced apoptosis in cultures of human Schwann cells. Neurosci. Lett. 392: 22-26. doi:10.1016/j.neulet.2005.08.068. PMID:16236448.
27. Kim, H.E., Krug, M.A., Han, I., Ensley, J., Yoo, G.H., Forman, J.D., and Kim, H.-R.C. 2000. Neutron radiation enhances cisplatin cytotoxicity independently of apoptosis in human head and neck carcinoma cells. Clin. Cancer Res. 6: 4142-4147. PMID:11051268.
28. Kim, R., Tanabe, K., Uchida, Y., Emi, M., Inoue, H., and Toge, T. 2002. Current statute of the molecular mechanisms of anticancer drug-induced apoptosis. Cancer Chemother. Pharmacol. 50: 343-352. doi:10.1007/s00280- 002-0522-7. PMID:12439591.
29. Korbelik, M., and Skov, K.A. 1989. Inactivation of hypoxic cells by cisplatin and radiation at clinically relevant doses. Radiat. Res. 119: 145-156. doi:10.2307/3577374. PMID:2756105.
30. Lambin, P., Scalliet, P., Coster, B., M'Vondo, J.C., Vynckier, S., Gueulette, J., and Wambersie, A. 1993. Influence of cisplatinum on intestinal tolerance to photon and neutron irradiation in mice. Radiother. Oncol. 26: 73-75. doi:10.1016/0167-8140(93)90029-8. PMID:8438090.
31. Lee, D.H., Han, J.-Y., Cho, K.H., Pyo, H.R., Kim, H.Y., Yoon, S.J., and Lee, J.S. 2005. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 63: 1037-1044. doi:10.1016/j.ijrobp.2005. 05.061. PMID:16024178.
32. Lee, A.W.M., Tung, S.Y., Chan, A.T.C., Chappell, R., Fu, Y.-T., Lu, T.-X., et al. 2006. Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 66: 142-151. PMID:16904519.
33. Lelieveld, P., Scoles, M.A., Brown, J.M., and Kallman, R.F. 1985. The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin. Int. J. Radiat. Oncol. Biol. Phys. 11: 111-121. PMID:4038500.
34. Machtay, M., Seiferheld, W., Komaki, R., Cox, J.D., Sause, W.T., and Byhardt, R.W. 1999. Is prolonged survival possible for patients with supraclavicular node metastases in non-small-cell lung cancer treated with chemoradiotherapy? Analysis of the Radiation Therapy Oncology Group experiences. Int. J. Radiat. Oncol. Biol. Phys. 44: 847-853. PMID:10386642.
35. Maduro, J.H., Pras, E., Willemse, P.H.B., and de Vries, E.G.E. 2003. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat. Rev. 29: 471-488. doi:10.1016/S0305-7372(03)00117-8. PMID:14585258.
36. Moertel, C.G., Childs, D.S., Reitemeier, R.J., Childs, D.S., Jr., Colby, M.Y., Jr., and Holbrook, M.A. 1969. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet, 294: 865-867. doi:10.1016/S0140-6736(69)92326-5.
37. Mulatero, C., McClaren, B.R., Mason, M., Oliver, R.T.D., and Gallagher, C.J. 2000. Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma. Br. J. Cancer, 83: 1612-1616. doi:10.1054/bjoc.2000.1480. PMID:11104554.
38. Muscella, A., Urso, L., Calabriso, N., Ciccarese, A., Migoni, D., Fanizzi, F.P., et al. 2005. Differential response of normal, dedifferentiated and transformed thyroid cell lines to cisplatin treatment. Biochem. Pharmacol. 71: 50-60. doi:10.1016/j.bcp.2005.10.022. PMID:16297374.
39. Nakamoto, S., Mitsuhashi, N., Takahashi, T., Sakurai, H., and Niibe, H. 1996. An interaction of cisplatin and radiation in two yolk sac tumour cell lines with different radiosensitivities in vitro. Int. J. Radiat. Biol. 70: 747-753. PMID:8980672.
40. Numico, G., Russi, E.G., Vitiello, R., Sorrentino, R., Colantonio, I., Cipolat, M., et al. 2006. Gemcitabline and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: A pharmacology-guided schedule. Int. J. Radiat. Oncol. Biol. Phys. 66: 731-737. PMID:17011449.
41. Petit, T., Velten, M., d'Hombres, A., Marchal, C., Montbarbon, X., Mornex, F., et al. 2007. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy. Gynecol. Oncol. 104: 104-108. doi:10.1016/j.ygyno.2006.07.034. PMID:16987544.
42. Pohl, G., Krajnik, G., Malayeri, R., Müller, R.-M., Klepetko, W., Eckersberger, F., et al. 2006. Induction chemotherapy with TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer. Lung Cancer, 54: 63-67. doi:10.1016/j.lungcan.2006.05.027. PMID:16926060.
43. Schneider, B.J., Ben-Josef, E., McGinn, C.J., Chang, A.E., Colletti, L.M., Normolle, D.P., et al. 2005. Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 63: 1325-1330. doi:10.1016/j.ijrobp.2005.04. 030. PMID:15993549.
44. Skov, K., and MacPhail, S. 1991. Interaction of platinum drugs with clinically relevant X-ray doses in mammalian cells: a comparison of cisplatin, carboplatin, iproplatin, and tetraplatin. Int. J. Radiat. Oncol. Biol. Phys. 20: 221-225. PMID:1991682.
45. Stemmler, H.J., Kahlert, S., Brudler, O., Beha, M., Müller, S., Stauch, B., and Heinemann, V. 2005. High efficacy of gemcitabine and cisplatin plus trastuzumab in patients with HER2-overexpressing metastatic breast cancer: a phase II study. Clin. Oncol. 17: 630-635. doi:10.1016/j.clon.2005.06. 010.
46. Tanabe, M., Godat, D., and Kallman, R.F. 1987. Effects of fractionated schedules of irradiation combined with cis-diamminedichloroplatinum(II) on SCCVII tumor and normal tissues of the C3H/Km mouse. Int. J. Radiat. Oncol. Biol. Phys. 13: 1523-1532. PMID:3624028.
47. Terheggen, P.M.A.B., Floot, B., Scherer, E., Begg, A.C., Fichtinger-Schepman, M.J., and Den Engelse, L. 1987. Immunocytochemical detection of interaction products of cis-diamminedichloroplatinum(II) (cis-DDP) and cis-diammine (1.1-cyclobutanedicarboxylato)-platinum(II) (CBDCA) with DNA in rodent tissue sections. Cancer Res. 47: 6719-6725. PMID:3315190.
48. Thomas, P., Robinet, G., Gouva, S., Fournel, P., Léna, H., Le Caer, H., et al. 2006. Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer. Lung Cancer, 51: 105-114. doi:10.1016/j.lungcan.2005.10.004. PMID:16310886.
49. Trodella, L., De Marinis, F., D'Angelillo, R.M., Ramella, S., Cesario, A., Valente, S., et al. 2006. Induction cisplatin-gemcitabine-paclitaxel plus concurrent radiotherapy and gemcitabine in the multimodality treatment of unresectable stage IIIB non-small cell lung cancer. Lung Cancer, 54: 331-338. doi:10.1016/j.lungcan.2006.07.020. PMID:17011065.
50. Twentyman, P.R., Wright, K.A., and Rhodes, T. 1991. Radiation response of human lung cancer cell lines with inherent and acquired resistance to cisplatin. Int. J. Radiat. Oncol. Biol. Phys. 20: 217-220. PMID:1846846.
51. Twentyman, P.R., Wright, K.A., and Mistry, P. 1992. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin. Cancer Res. 52: 5674-5680. PMID:1327513.
52. Vaishampayan, U.N., Ben-Josef, E., Philip, P.A., Vaitkevicius, V.K., Du, W., Levin, K.J., and Shields, A.F. 2002. A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies. Int. J. Radiat. Oncol. Biol. Phys. 53: 675-679. PMID:12062611.
53. van Rongen, E., Kuijpers, W.C., and Baten-Wittwer, A. 1994. The influence of platinum drugs on radiation response of rat kidneys. Radiother. Oncol. 31: 138-150. doi:10.1016/0167-8140(94)90394-8. PMID:8066193.